| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.79 | 0.002 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |